WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke DIAGNOSTICS DEFINING THERAPY wurde als Wortmarke am 21.12.2018 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1467839 |
| Länder | 
|
| Basismarke |
Nr. 1939288,
06. Juli 2018
|
| Anmeldedatum | 21. Dezember 2018 |
| Ablaufdatum | 21. Dezember 2028 |
Markeninhaber
Suite G16,
National Innovation Centre,
AU
National Innovation Centre,
AU
Markenvertreter
Level 14,
255 Elizabeth Street
AU
Waren und Dienstleistungen
01
Chemicals used in industry, science, photography,
agriculture, horticulture and forestry; reagents and
reactants in this class; enzymes for industrial or
scientific purposes; nucleic acid; nucleic recombinant
acids; acids for industrial purposes; polymerase; chemicals
used in food processing and screening; chemicals used in
environmental monitoring
05
Pharmaceutical and veterinary preparations and substances;
reagents for medical and veterinary use; nucleic acid
amplification reagents for medical use; nucleic acid
sequencing programs for medical use; chemical preparations
containing enzymes for medical purposes; chemical
preparations containing enzymes for pharmaceutical,
veterinary and medical purposes; enzymes for pharmaceutical,
veterinary and medical purposes; medical kits containing
medical and/or pharmaceutical preparations; clinical
diagnostics for medical or veterinary use; biological
chemical test kits for medical laboratory use in analysis of
gene expression, protein expression, metabolite expression,
inflammation, immune-suppression, immune disorders
10
Surgical, medical and veterinary apparatus and instruments;
diagnostic testing apparatus and instruments for medical
purposes; diagnostic testing kits containing diagnostic
testing apparatus; point of care medical devices; screening
kits in this class for the diagnosis of disease, detection
and/or identification of pathogens, for the detection of
antibiotic resistance, for the analysis of gene expression,
protein expression, metabolic expression, inflammation, and
immune-suppression and/or immune disorders for genotyping,
analysis of polymorphisms, detection of acquired or
inherited genetic mutations, detection and/or analysis of
epigenetic alterations, analysis of response to therapy
42
Scientific and technological services and research and
design relating thereto; genetic research; genetic
engineering services; scientific research in the field of
genetics and genetic engineering; scientific research
relating to genetics; chemistry services; research relating
to chemistry; scientific research relating to chemistry;
research in the field of chemistry; laboratory analysis in
the field of chemistry; development of diagnostic apparatus;
design of diagnostic apparatus; research relating to
molecular sciences; analysis of data generated by scientific
and medical experiments and tests; biological,
bacteriological, chemical, biochemical, dna, rna, protein,
polynucleic acid and molecular analysis and evaluation
services; dna and rna and polynucleic acid and protein
sequencing, analysis and evaluation services; genome
sequencing services and the analysis and evaluation of data
resulting therefrom; provision of reports relating to
scientific and medical experiments, the results of
scientific and medical experiments and tests, the analysis
and evaluation of scientific and medical data, and data
generated by scientific and medical experiments and tests;
scientific and medical research and development services;
custom design and development of biochemical assays;
molecular diagnostics testing
44
Medical services; human healthcare services; medical testing
services relating to the diagnosis and treatment of disease;
genetic testing for medical purposes; medical and health
services relating to dna, genetics and genetic testing;
medical diagnostic services (testing and analysis);
providing collected and analysed medical information in the
field of genetic and treatment information for diseases and
disorders for diagnostic and treatment purposes; diagnostic
imaging and molecular medicine
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 18. Februar 2021 | 2021/8 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 18. Januar 2021 | 2021/3 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 23. November 2020 | 2020/50 Gaz | EM | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 06. September 2020 | 2020/37 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 23. Juli 2020 | 2020/30 Gaz | JP | Ablehnung |
| 27. März 2020 | 2020/14 Gaz | KR | Ablehnung |
| 23. Juli 2019 | 2019/31 Gaz | CN | Ablehnung |
| 24. Juni 2019 | 2019/26 Gaz | US | Ablehnung |
| 13. Juni 2019 | 2019/25 Gaz | EM | Ablehnung |
| 21. Dezember 2018 | 2019/19 Gaz | AU | Eintragung |
ID: 141467839